Volume 15, Issue 10, Pages (October 2008)

Slides:



Advertisements
Similar presentations
Volume 13, Issue 10, Pages (October 2006)
Advertisements

Volume 28, Issue 4, Pages (November 2007)
John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Volume 142, Issue 4, Pages e3 (April 2012)
Structural Basis for the Highly Selective Inhibition of MMP-13
Mikael Peräkylä, Ferdinand Molnár, Carsten Carlberg 
Casey C. Fowler, Eric D. Brown, Yingfu Li  Chemistry & Biology 
Structure and Protein Design of a Human Platelet Function Inhibitor
Volume 21, Issue 1, Pages (January 2013)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Volume 3, Issue 3, Pages (March 1999)
X-Ray Structure of the hRORα LBD at 1.63 Å
Volume 9, Issue 2, Pages (February 2002)
N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz, D. Moras 
Volume 23, Issue 3, Pages (March 2016)
The Transcriptional Coactivator DRIP/Mediator Complex Is Involved in Vitamin D Receptor Function and Regulates Keratinocyte Proliferation and Differentiation 
Volume 11, Issue 6, Pages (June 2004)
Volume 19, Issue 8, Pages (August 2012)
Structure-Based Design of Covalent Siah Inhibitors
Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases1  Yvonne Bury, Dagmar Ruf, Carsten Carlberg  Journal.
Volume 115, Issue 2, Pages (October 2003)
Volume 21, Issue 6, Pages (March 2006)
Interaction between Vitamin D Receptor and Vitamin D Ligands
Volume 14, Issue 7, Pages (July 2007)
John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Volume 16, Issue 6, Pages (December 2004)
Volume 14, Issue 5, Pages (May 2007)
The Nuclear Xenobiotic Receptor CAR
Volume 28, Issue 4, Pages (November 2007)
Structural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism
Volume 10, Issue 4, Pages (February 2015)
Volume 18, Issue 5, Pages (May 2011)
Volume 24, Issue 8, Pages e7 (August 2017)
Volume 13, Issue 10, Pages (October 2006)
Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor  Yong Li, Kelly Suino,
Volume 23, Issue 3, Pages (March 2016)
Volume 15, Issue 10, Pages (October 2008)
Volume 15, Issue 10, Pages (October 2008)
Hong Ye, Young Chul Park, Mara Kreishman, Elliott Kieff, Hao Wu 
Volume 31, Issue 6, Pages (December 2009)
Volume 15, Issue 9, Pages (September 2008)
Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells  S. Chen, K. Olsen, C. Grigsby, D.G.
Volume 14, Issue 7, Pages (July 2007)
Mikael Peräkylä, Ferdinand Molnár, Carsten Carlberg 
Volume 15, Issue 6, Pages (June 2007)
Partial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 16, Issue 12, Pages (June 2006)
Molecular Basis of Drug Resistance in Aurora Kinases
Volume 17, Issue 11, Pages (November 2010)
Volume 16, Issue 6, Pages (June 2009)
Volume 13, Issue 3, Pages (February 2004)
Volume 8, Issue 4, Pages (October 2010)
Native Chemical Ligation in Covalent Caspase Inhibition by p35
Volume 22, Issue 9, Pages (September 2015)
Crystal Structures of the Thi-Box Riboswitch Bound to Thiamine Pyrophosphate Analogs Reveal Adaptive RNA-Small Molecule Recognition  Thomas E. Edwards,
Volume 17, Issue 4, Pages (February 2005)
Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor  Yong Li, Kelly Suino,
Structural Basis of Swinholide A Binding to Actin
Geetanjali J. Jog, Jun Igarashi, Hiroaki Suga  Chemistry & Biology 
Volume 19, Issue 8, Pages (August 2012)
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Partial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Volume 20, Issue 1, Pages (January 2012)
Mark S. Dunstan, Debraj GuhaThakurta, David. E. Draper, Graeme L. Conn 
Volume 19, Issue 2, Pages (February 2012)
Volume 16, Issue 6, Pages (December 2004)
Volume 9, Issue 2, Pages (February 2002)
Presentation transcript:

Volume 15, Issue 10, Pages 1029-1034 (October 2008) Superagonistic Fluorinated Vitamin D3 Analogs Stabilize Helix 12 of the Vitamin D Receptor  Guy Eelen, Noelia Valle, Yoshiteru Sato, Natacha Rochel, Lieve Verlinden, Pierre De Clercq, Dino Moras, Roger Bouillon, Alberto Muñoz, Annemieke Verstuyf  Chemistry & Biology  Volume 15, Issue 10, Pages 1029-1034 (October 2008) DOI: 10.1016/j.chembiol.2008.08.008 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 Chemical Structure of 1,25(OH)2D3 and Analogs and their Prodifferentiating Effects on SW480-ADH Colon Cancer Cells (A) Chemical structure of the fluorinated nonsteroidal D-ring analogs CD578, WU515, and WY1113. (B) Differentiation of SW480-ADH cells demonstrated by phase-contrast micrographs of SW480-ADH cells treated with 10−10 or 10−9 M of each compound for 3 days. A representative experiment is shown. Scale bar = 40 μm. (C) Western blotting analysis of the expression of E-cadherin, c-Myc, and β-actin (loading control) in SW480-ADH cells at 48 h of treatment with the indicated doses of each compound. A representative experiment is shown. Chemistry & Biology 2008 15, 1029-1034DOI: (10.1016/j.chembiol.2008.08.008) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Effects of 1,25(OH)2D3 and Analogs on β-Catenin/TCF and VDR Transcriptional Activity (A) SW480-ADH cells were transfected with the wild-type (TOP-flash) or mutated (FOP-flash) β-catenin-TCF-responsive reporter plasmids and then treated with 1,25(OH)2D3 or each analog (10−7 M) for 48 h. Mean values (TOP/FOP ratio, expressed as percentages of vehicle-treated cells) ± stdev obtained in three experiments using triplicates are shown. ∗Inhibition different from inhibition by 1,25(OH)2D3 at the same dose according to Student's t test (p < 0.05). (B) SW480-ADH colon cancer cells were transfected with a construct containing the Firefly luciferase gene under the control of four copies of a direct repeat 3 (DR3) VDRE. After 48 h incubation in the presence or absence of the indicated doses of 1,25(OH)2D3 or analogs, luciferase activities were measured and normalized as described in the Supplemental Data. Bars represent fold increase ± standard deviation in normalized luciferase activity for 1,25(OH)2D3- or analog-treated cells as compared with vehicle-treated cells. ∗Fold increase different from fold increase for 1,25(OH)2D3 at the same dose according to Student's t test (p < 0.05). A representative experiment performed in triplicate is shown. (C) Induction of VDR-SRC-1 interaction by transfecting human colon cancer Caco-2 cells with pVPVDR, pSG424-SRC1-NIR, pG5-LUC, and pcDNA3.1(−)/Myc-His/lacZ for normalization and treated with the different ligands at the indicated doses. A representative experiment of three independent experiments is shown. Data are the mean ± standard deviation of triplicate samples. ∗Relative luciferase units (RLU) different from RLU for 1,25(OH)2D3 at the same dose according to Fisher's LSD multiple-comparison test (α = 0.05). Chemistry & Biology 2008 15, 1029-1034DOI: (10.1016/j.chembiol.2008.08.008) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 3 Conformation of the VDR-Bound CD578 Analog (A) The analog CD578 is shown in its Fo-Fc electron density omit maps contoured at 3.0σ. The ligand is shown in stick representation with carbon, oxygen, and fluorine atoms in green, red, and sky blue, respectively. (B) Stereo view of the conformation of the bound ligands. CD578 (green) and 1,25(OH)2D3 (pink) are shown in stick representation after superimposed VDR complexes. Chemistry & Biology 2008 15, 1029-1034DOI: (10.1016/j.chembiol.2008.08.008) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 4 Close-up View of 1,25(OH)2D3 and Analog CD578 in the VDR LBD Pocket (A) Stereo views around D ring. (B) 25-OH of CD578 (green) and 1,25(OH)2D3 (pink) in the VDR LBD pocket. Carbon atoms of the residues, which are closer than 4.0 Å and important for comparison, are shown in light green and white for CD578 and 1,25(OH)2D3, respectively. Nitrogen, oxygen, and fluorine atoms are shown in blue, red, and sky blue, respectively. Dotted lines represent hydrogen bonds of the CD578 complex. Chemistry & Biology 2008 15, 1029-1034DOI: (10.1016/j.chembiol.2008.08.008) Copyright © 2008 Elsevier Ltd Terms and Conditions